PLRZ (Polyrizon) EBITDA Margin %: 0.00% (As of Dec. 2025)


PLRZ Polyrizon Ltd PLRZ
14 GF Score
Price $12.60
! 4 Warning Signs
View Full Analysis

What is Polyrizon EBITDA Margin %?

Polyrizon PLRZ -0.08% 14 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates PLRZ with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 940 Biotechnology companies, Polyrizon ranks worse than 106382.87% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Polyrizon's EBITDA for the six months ended in Dec. 2025 was $-3.15 Mil. Polyrizon's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Polyrizon's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

Polyrizon  (NAS:PLRZ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Polyrizon EBITDA Margin % Related Terms

Polyrizon EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Polyrizon's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polyrizon EBITDA Margin % Chart

Polyrizon Annual Data
Trend Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
0.00 0.00 0.00 0.00

Polyrizon Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

PLRZ vs SKYE, NEUP, LGVN: EBITDA Margin % Comparison

For the Biotechnology subindustry, Polyrizon's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polyrizon EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Polyrizon's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Polyrizon's EBITDA Margin % falls into.


PLRZ
14GF Score
Polyrizon Ltd PLRZ
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polyrizon EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Polyrizon's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.443/0
= %

Polyrizon's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.147/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Polyrizon (PLRZ) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Polyrizon and its competitors. According to the industry distribution chart, Polyrizon ranks #999999 out of 940 companies in the Biotechnology industry.
Is Polyrizon's EBITDA Margin % too high?
Polyrizon's current EBITDA Margin % is 0.00%. Based on the distribution chart, Polyrizon ranks #999999 out of 940 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Polyrizon has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Polyrizon's EBITDA Margin % compare to SKYE and NEUP?
According to the Biotechnology industry distribution chart, Polyrizon ranks #999999 out of 940 companies for EBITDA Margin %. This places Polyrizon in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Polyrizon and its competitors. Polyrizon's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polyrizon stock overvalued right now?
Polyrizon (PLRZ) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Polyrizon's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Polyrizon (PLRZ), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polyrizon Business Description

Address 5 Ha-Tidhar Street, Raanana, ISR, 4366507
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
14GF Score

Get the complete analysis for PLRZ

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.60
Price